DNTH

NASDAQStock

Dianthus Therapeutics, Inc.

$77.92-2.31 (-2.88%)

52-Week Range

$14.86

$86.92

Key Stats

Market Cap

2.8B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24

Volume

762.3K

Avg Volume

1.5M

Performance

+60.90%

+91.60%

+116.85%

YTD

+102.42%

+277.44%

+542.05%

Price Chart

ETF Exposure

DNTH is held by 64 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	12	$1K	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	13	$1K	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	16	$1K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	13	$1K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	9	$750	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	7	$567	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	3	$251	$9.5M	0.12%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	2	$178	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	7	$588	$81.5M	0.10%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	753	$33K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	753	$33K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	753	$33K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	753	$33K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	753	$33K	$3.7M	0.70%

PreviousPage 2 of 2

About DNTH ETF Exposure

Dianthus Therapeutics, Inc. (DNTH) is held by 64 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.8B, DNTH is a widely held institutional stock. The stock currently trades at $77.92. Investors can gain exposure to DNTH through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold DNTH, sorted by portfolio weight.